- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02797925
Mechanisms Behind Development of Tendinopathy (TESINaC)
Mechanisms Behind Development of Tendinopathy: Early Structural, Inflammatory, Nociceptive and Clinical Changes in Recreational Runners
Study Overview
Detailed Description
The investigators intend to study the development of tendinopathy in humans that enter a phase of relative overloading of their tendons. This will be done in a large cohort of individuals from whom the investigators have obtained basic data and tests. A percentage of these participants will develop overuse symptoms and in those the investigators will perform investigations that will identify the initial pathological changes in tendinopathy
Participants are included as soon as possible after diagnosis of either Achilles or patella tendinopathy because the investigators wish to investigate the early changes in tendinopathy. The hypothesis is, that at the early development of tendinopathy there will be a mismatch between matrix protein anabolic and catabolic pathways, and will be associated with a secondary upregulation of inflammatory and apoptotic markers in the tendon and result in hypervascularization and hyper-metabolism.
Recruiting participants will be done in collaboration with local athletic clubs in the Copenhagen area. The athletic clubs include Sparta, Københavns Idræt Forening (KIF), Frederiksberg Idræt Forening (FIF). Furthermore, the investigators will establish contact through online social media such as Facebook, Twitter and Google. In addition, Information leaflets will be handed out, and medical staff at the emergency rooms repeatedly informed about the project. Healthy participants can be directly recruited by participants already in the project, social medias and through information leaflets handed out. It is planned to inform staff at the emergency rooms at Bispebjerg Hospital, Amager Hospital, Gentofte Hospital, Herlev Hospital and Hvidovre Hospital. Patients and healthy controls can contact the primary investigator directly through email or telephone.
Recruitment to project TESINaC will focus onset of exercise pain and every participant will be evaluated by a doctor if the participant have tendinopathy or not. Once included the participant will undergo following procedures as soon as possible after diagnosis is given:
- Questionnaire regarding training history and ongoing symptoms
- Ultrasound scanning of tendons
- Ultrasound isometric
- Blood samples
- MRI of tendons on both legs MRI precedes biopsy as it can identify any diseased area within the tendon from which a biopsy can be taken. Only participants with tendinopathy will have to undergo biopsy from both patella tendons once during the project. Healthy participants will not undergo biopsy. No biopsy will be taken from the Achilles tendon as this procedure may worsen the participants symptoms.
Participants with tendinopaty will get physical reevaluated after 3, 6 and 12 months as regards to symptoms, activity of daily life, blood samples, questionnaires VISA-A/P and ultrasound measurements. Rehabilitation training of patients is expected to start as soon as possible after the biopsy have been taken.
Healthy participants will not be reevaluated nor will they undergo rehabilitation training.
It is expected that the results from this study will provide insight into the events leading up to a developing tendinopati. This study will add important information to understand the pathophysiology and provide information on timing of the phases as well. Information and results from the study will give insight into better treatment options that is more specific and earlier intervention on the individual basis. Furthermore, this study will investigate and address the question why some people develop tendinopathies and others do not when the training volume is equally raised.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Peter Tran, Doctor
- Phone Number: +45 27428164
- Email: Tesinac2016@gmail.com
Study Locations
-
-
Kbh NV
-
Copenhagen, Kbh NV, Denmark, 2400
- Recruiting
- Bispebjerg Hospital
-
Contact:
- Peter Tran, Doctor
- Phone Number: 0045 35316086
- Email: tesinac2016@gmail.com
-
Contact:
- Nikolaj Malmgaard-Clausen, Doctor
- Email: nikolajmoelkjaer@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Marked tendon related pain in association with exercise on one leg
- Soreness during physical examination of patella or/and Achilles tendon upon palpation
- Demonstrate an ultrasonographic (US) thickening of the tendon (2 mm larger on the affected side vs the contralateral un-symptomatic side in the anterior-posterior projection)
Exclusion Criteria:
- Surgery in Achilles and/or patella tendon
- History of Achilles and/or patella tendinopathy
- Received any form of injection in Achilles and/or patella tendon
- Lately have infection around Achilles and/or patella tendon
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Tendinopathy
Long slow strength training for 3 months that are performed at home or gym.
Participants receive initial guidance to the exercises from a physiotherapist assigned to Bispebjerg H.
|
Long slow strength training of the tendon for 3 months to improve function
Other Names:
|
Healthy
No intervention. No training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Investigate the timespan of inflammation from acute phase to resolution in tendinopathy
Time Frame: 3 months
|
Markers for inflammation includes tendon thickness, vascularization, inflammatory mRNA leves, inflammatory protein signals and mechanical properties of tendon.
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measure tendon thickness in mm (anterior-posterior) on ultrasound
Time Frame: 3 months
|
3 months
|
|
Measure TNF-alpha mRNA levels in patella biopsies as ratio to GAPDH
Time Frame: 3 months
|
GAPDH is a household gene and therefore expected to have constant mRNA levels.
TNF-alpha mRNA is measured relative to GAPDH.
|
3 months
|
Measure the tendon region with maximal vascularization on ultrasound doppler signal based on visual impression from the investigators
Time Frame: 3 months
|
The region with maximal vascularization is based on where the ultrasound doppler signal is most abundant, which depends on visual impression from the investigators.
|
3 months
|
IHC stain for TNF-alpha protein signal in patella biopsies with specific antibodies
Time Frame: 3 month
|
Quantification is made by visual inspection of stained tendon samples
|
3 month
|
Measure tendon mechanical properties with ultrasound isometric
Time Frame: 3 months
|
Tracking software provide details about deformation of tendon in mm, young modulus, max % strain and stiffness.
|
3 months
|
Measure CRP levels in blood samples
Time Frame: 3 months
|
Systemic inflammation
|
3 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Michael Kjær, Professor, Clinical Medicine
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BBH-128
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tendinopathy
-
University of CadizNot yet recruitingTendinopathy | Achilles Tendinopathy | Tendinopathy, Elbow | Patellar Tendinopathy | Tendinopathy Rotator CuffSpain
-
University of CalgarySport Science Association of Alberta (SSAA)UnknownAchilles Tendinopathy | Achilles Tendon Enthesopathy | Mid-Portion Achilles Tendinopathy | Insertional Achilles Tendinopathy | Non-Insertional Achilles TendinopathyCanada
-
Krankenhaus Barmherzige Schwestern LinzActive, not recruitingAchilles Tendinopathy | Insertional Achilles TendinopathyAustria
-
Brooke Army Medical CenterRecruitingLateral Elbow TendinopathyUnited States
-
Guna S.p.aRecruitingTendinopathy | Achilles Tendinopathy | Insertional Achilles Tendinopathy | PeritendinitisItaly
-
Elif Balevi BaturCompleted
-
Anika Therapeutics, Inc.Completed
-
University of DelawareRecruitingSever's Disease | Achilles Tendinopathy | Insertional Achilles Tendinopathy | Apophysitis; CalcaneusUnited States
-
Musculoskeletal Injury Rehabilitation Research...The Geneva Foundation; Fort Belvoir Community HospitalRecruitingAchilles TendinopathyUnited States
-
Gelderse Vallei HospitalRecruiting
Clinical Trials on Training
-
University of Trás-os-Montes and Alto DouroCompletedLipid Metabolism Disorders | Sarcopenia | Osteoporosis | Overweight and Obesity | Personal Satisfaction | Hypertension With Complications and Secondary HypertensionPortugal
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedHypertension | Diabetes | Peripheral Arterial DiseaseBrazil
-
New Jersey Institute of TechnologyRutgers, The State University of New JerseyCompletedHemiplegia | Hemiparesis | Cerebrovascular AccidentUnited States
-
Riphah International UniversityRecruiting
-
University of PittsburghEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Poznan University of Physical EducationPoznan University of Medical Sciences; National Science Centre, PolandActive, not recruitingHealthy Athletes Aged 18-35 YearsPoland
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedHyperglycemia | Diabetes Mellitus, Type 2Norway
-
Lebanese UniversityCompletedHeart Failure | Quality of Life | Cardiac Rehabilitation | Aerobic Exercise | Exercise Intolerance | Respiratory Muscle Training | Strength Training